Adaptive Biotechnologies Corporation Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ADPT Company Description
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
ADPT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ADPT Smart Score
Score Breakdown
ADPT Company Description
Show More
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL). Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ADPT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ADPT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ADPT's company Twitter account
WallStreetBets
Number of mentions of ADPT in WallStreetBets Daily Discussion
ADPT News
Recent insights relating to ADPT
CNBC Recommendations
Recent picks made for ADPT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ADPT
Corporate Flights
Flights by private jets registered to ADPT
Our Analysis